Wednesday, June 16, 2021

CSIR Indian Institute of Chemical Technology, Hyderabad has licensed process knowhow for synthesis of 2-Deoxy-D-Glucose to Lee Pharma Ltd.

Indian Institute of Chemical Technology, (IICT), a constituent laboratory of CSIR and Lee Pharma, an integrated pharmaceutical company, based in Hyderabad have entered into a non-exclusive licensing agreement for the synthesis of 2-Deoxy-D-Glucose (2-DG). Recently, 2-DG developed by DRDO and Dr Reddy’s Laboratories has received approval for use in Covid-19 patients.

Recently, 2-DG developed by DRDO and Dr Reddy’s Laboratories has received approval for use in Covid-19 patients. It has been found to help speed up recovery and reduce oxygen dependence and Dr. Reddy’s Laboratories has launched the drug in the form of sachets.

Lee Pharma informed that they would file the application for getting the approval from DCGI, New Delhi. Lee Pharma will manufacture and commercialize the 2-DG sachets from their formulation facility located at SEZ, Duvvada, Visakhapatnam, Andhra Pradesh, which has the accreditations, by global regulatory agencies.

Dr Srivari Chandrashekar, Director CSIR-IICT highlighted that “There is role of CSIR in development of 2-DG, as CSIR-CCMB tested the drug on SARS-CoV-2 viral cultures. CSIR has been engaged in development of drugs for treatment of Covid-19 and has undertaken many clinical trials for repurposed drugs. Additionally, this agreement with Lee Pharma Ltd. is towards increasing affordable therapeutic options for treatment of Covid-19”.

Raghumitra Alla, Director, Lee Pharma said, “This collaboration with CSIR-IICT for 2-DG, API is part of our broader strategy for enhancing Covid-19 treatment options. Further CSIR-IICT, Hyderabad is well-known for its high quality research & development of various new molecules and we feel proud to be associated with them.”

By Tapas Bhattacharya

- Advertisement -
Latest news

Need to bring Broadcasting to Smartphones through convergence between 5G Broadcasting & Cellular Standards: Prasar Bharati CEO

Technology has been a huge enabler and rescuer during the pandemic, says Prasar Bharati CEO Shashi S Vempati Prasar Bharati CEO, Shashi Shekhar Vempati addressed...

Member (Health) Niti Aayog, Dr Paul stresses on COVID appropriate behaviour and creating micro containment zones across country

Member (Health) Niti Aayog Dr. Paul has stressed on effective containment of COVID pandemic by following COVID appropriate behaviour and creating micro containment zones...

Maharashtra govt to provide Rs. 5 lakh assistance to children who have lost their parents during Corona period

Maharashtra Women and Child Development Minister Yashomati Thakur has said that the state government will provide all kinds of assistance to the children who...

Nasdaq index and S&P 500 gain while Dow Jones index falls in US equity market

In the US equity market, the Nasdaq index and the S&P 500 gained yesterday. In the lack of catalysts the Dow Jones index fell...
Related news

Need to bring Broadcasting to Smartphones through convergence between 5G Broadcasting & Cellular Standards: Prasar Bharati CEO

Technology has been a huge enabler and rescuer during the pandemic, says Prasar Bharati CEO Shashi S Vempati Prasar Bharati CEO, Shashi Shekhar Vempati addressed...

Member (Health) Niti Aayog, Dr Paul stresses on COVID appropriate behaviour and creating micro containment zones across country

Member (Health) Niti Aayog Dr. Paul has stressed on effective containment of COVID pandemic by following COVID appropriate behaviour and creating micro containment zones...

Maharashtra govt to provide Rs. 5 lakh assistance to children who have lost their parents during Corona period

Maharashtra Women and Child Development Minister Yashomati Thakur has said that the state government will provide all kinds of assistance to the children who...

Nasdaq index and S&P 500 gain while Dow Jones index falls in US equity market

In the US equity market, the Nasdaq index and the S&P 500 gained yesterday. In the lack of catalysts the Dow Jones index fell...